NASDAQ:PRME

Prime Medicine Stock Forecast

etoro logo Buy PRME
*Your capital is at risk
$2.92
-0.100 (-3.31%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of PRME AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PRME to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Prime Medicine, Inc.
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jul 22, 2026 Loss -5.50%

The Prime Medicine, Inc. stock price fell by -3.31% on the last day (Friday, 31st Jul 2026) from $3.02 to $2.92. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.47% from a day low at $2.91 to a day high of $3.04. The price has fallen in 7 of the last 10 days and is down by -6.71% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -302 thousand shares and in total, 2 million shares were bought and sold for approximately $5.34 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.84 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.88% during the next 3 months and, with a 90% probability hold a price between $2.97 and $4.91 at the end of this 3-month period.

PRME Signals & Forecast

There are few to no technical positive signals at the moment. The Prime Medicine, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.00 and $3.34. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -36.80%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Wednesday, June 10, 2026 and based on theory for this formation the price should go up by 46.16% to $4.27 within 15 trading days (Thursday, July 02, 2026) since signal was issued.

Support, Risk & Stop-loss for Prime Medicine, Inc. stock

Prime Medicine, Inc. finds support from accumulated volume at $2.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.130 between high and low, or 4.47%. For the last week, the stock has had daily average volatility of 6.07%.

Prime Medicine, Inc. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $2.73 (-6.56%) (This stock has very high daily movements and this gives very high risk. Low RSI14 is 22 which reduces the risk some. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (PRME) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Prime Medicine, Inc. to open at $2.96, and during the day (based on 14 day Average True Range), to move between $2.80 and $3.04, which gives a possible trading interval of +/-$0.247 (+/-8.82%) up or down from last closing price. If Prime Medicine, Inc. takes out the full calculated possible swing range there will be an estimated 8.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.90 (0.68%) than the resistance at $3.30 (13.01%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Prime Medicine, Inc. will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.240. We will update the financials statements for Prime Medicine, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.18% in the first trading day after earnings release.

Is Prime Medicine, Inc. stock A Buy?

Prime Medicine, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.217 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $2.96 ( 1.26%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PRME Performance

Trading levels for PRME

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.09 5.71%
R2 3.04 4.01%
R1 3.01 2.96%
Price 2.92
S1 2.91 -0.445%
S2 2.88 -1.50%
S3 2.83 -3.20%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.47 18.84%
R2 3.43 17.47%
R1 3.30 13.01%
Price 2.92
S1 2.90 -0.685%
S2 2.81 -3.77%
S3 2.71 -7.19%

PRME Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 10, 2019 Sep 10, 2019 Sep 10, 2019 $0.80 0%
2 Jun 14, 2019 Jun 14, 2019 Jun 14, 2019 $0.200 0%
3 Dec 18, 2018 Dec 18, 2018 Dec 18, 2018 $0.213 0%
4 Sep 14, 2018 Sep 14, 2018 Sep 14, 2018 $0.233 0%
5 Jun 21, 2018 Jun 21, 2018 Jun 21, 2018 $0.146 0%

FAQ

What is the symbol for Prime Medicine, Inc. Stock and on which exchange is it traded?
The symbol for Prime Medicine, Inc. is PRME and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Prime Medicine, Inc. Stock?
Prime Medicine, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Prime Medicine, Inc. Stock?
Prime Medicine, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Prime Medicine, Inc. Stock.

What's the current price of Prime Medicine, Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Prime Medicine, Inc. (PRME) share was $2.92.

What is the 52-week high and low for Prime Medicine, Inc. Stock?
The 52-week high for Prime Medicine, Inc. Stock is $6.94 and the 52-week low is $2.67.

What is the market capitalization of Prime Medicine, Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Prime Medicine, Inc. is 527.403M.

When is the next earnings date for Prime Medicine, Inc.?
The upcoming earnings date for Prime Medicine, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE